R&D Digital Lead

Location: London, UK
Job Type: Full-Time
Employer: GlaxoSmithKline
As the R&D Digital Lead, you will be responsible for partnering across all GSK Consumer Health categories to develop a strategic pipeline of digital healthcare innovation. This will include pioneering new, creative approaches to develop intuitive digital diagnostics and therapeutics, as well as evaluating digital devices/sensors/apps either marketed or in various stages of development. You will be a key contributor to the R&D innovation strategy to deliver digital innovation including: devices, wearables, software, and apps.

You will lead a team with responsibility for overall prototype design from concepts through large scale manufacturing with contract manufacturers. You will be a member of the Digital Innovation Hub (DIH) Leadership Team and serve on the Digital Innovation Board (DIB).

Key Responsibilities

  • You will be responsible for managing a portfolio of digital health opportunities to deliver at least one opportunity per year.
  • You will set the strategy and manage a team of ~10 direct & indirect cross-functional reports (Regulatory, Medical, Quality, Supply, Technical Leads, etc.) to provide expert support/project input to device innovation projects in close partnerships with the category project teams/management as well as establish new innovation platform areas.
  • As the successful incumbent, you will establish and maintain world-leading, cross-functional capabilities in a newly established Digital Innovation Hub and enable rapid prototyping (hardware/sensors, apps, etc.) capabilities for early stage Consumer Science evaluation.
  • You will create partner selection criteria for various partner categories. Manage internal and external partners to step-change GSK Consumer Healthcare ability to drive big-bet, digital breakthrough global innovation across all categories.
  • In this role, you will establish new research platforms into new technologies to enable digital diagnostics and treatment aids, including IP strategy.

Closing date for applications: May 15th 2018

Basic qualifications

  • BSc in Computer Science, Physics or Engineering ideally with a Business degree or equivalent
  • Significant and broad experience in device product development
  • Knowledge and deep understanding of the digital health (devices/apps/data) and broader trends in healthcare landscape.
  • Strong and broad understanding of deep scientific knowledge with ability to translate into new cross-category global platforms.
  • Excellent analytical and strategic thinking skills with strong expertise in managing multi-disciplinary, matrixed teams.
  • Excellent leadership and communication skills given large portfolio impact and multiple 1:1 interactions with senior internal / external stakeholders.
  • Line leader experience

Preferred qualifications

  • MA/MS/MBA in Computer Science, Engineering or Business
  • Advanced education in digital health (AI, devices, apps, etc.) and business.

Apply for this job

About GSK

GSK - a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.

Post your job offer now to start hiring the best digital health talent! For further information, please contact us.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...